Lanzhou Heshengtang Pharmaceutical

Lanzhou Heshengtang Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern pharmaceutical products. Headquartered in Lanzhou, Gansu Province, the company leverages the region's abundant herbal resources, particularly licorice, to produce a wide range of respiratory, cardiovascular, and pediatric treatments. Its flagship products include Compound Licorice Tablets and Dandie Granules, which are widely distributed across the Chinese market. The company operates state-of-the-art GMP-certified facilities and is recognized as a high-tech enterprise and a "Little Giant" for its innovation in TCM modernization. Heshengtang is publicly traded on the National Equities Exchange and Quotations (NEEQ) under the symbol 834466. Through its focus on quality and regional resource integration, the company has established itself as a key player in the Northwest China pharmaceutical industry.